查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1662692

2030 年糖尿病潰瘍治療市場預測：按類型、治療類型、最終用戶和地區進行的全球分析

Diabetic Ulcer Treatment Market Forecasts to 2030 - Global Analysis by Type (Foot Ulcers, Leg Ulcers, Mouth Ulcer, Skin Ulcer and Other Types), Treatment Type (Wound Care Dressings, Biologics and Wound Care Devices), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球糖尿病潰瘍治療市場價值為 45 億美元，預計到 2030 年將達到 83 億美元，預測期內的複合年成長率為 10.5%。

糖尿病潰瘍治療是指採用醫療措施修復糖尿病患者皮膚上（通常發生在足部和小腿）出現的潰瘍或潰瘍。高血糖、神經損傷和血液循環不良都會影響身體癒合傷口的能力，導致潰瘍。治療包括控制血糖值、傷口護理、預防感染和保持腳部清潔。先進的治療方法可能包括清創、減壓裝置、敷料，在極端情況下還包括手術。

根據 JAMA Network 報導，罹患糖尿病足潰瘍 (DFU) 的一生風險為 19-34%。

糖尿病盛行率不斷上升

糖尿病盛行率的上升是糖尿病潰瘍治療市場發展的主要驅動力。隨著血液循環不良和神經損傷等糖尿病相關併發症的增加，糖尿病足潰瘍的發生率不斷上升，對有效治療的需求也越來越大。病例激增推動了對先進創傷護理解決方案的需求，包括敷料、清創和感染控制。此外，治療方法的創新和對早期療育重要性的認知不斷提高也促進了市場的擴大。

醫療費用高昂

治療費用高是阻礙糖尿病潰瘍治療市場成長的主要因素。患者，尤其是低收入社區的患者，難以獲得先進的治療，從而限制了他們獲得有效護理的機會。經濟負擔常會導致治療延誤，進而造成患者治療效果較差。此外，醫療保健系統在長期照護資金方面面臨挑戰，影響了高成本糖尿病潰瘍治療的市場需求。這些經濟障礙阻礙了創新治療方法的採用。

治療方案的進展

治療方案的進步正在極大地推動糖尿病潰瘍治療市場的發展。先進的傷口敷料、生長因子療法、幹細胞療法和再生醫學等創新技術正在改善癒合並減少併發症。此外，傷口護理（NPWT）和生物工程皮膚替代等技術正在提高恢復率。這些突破性技術正在提高治療效果、改善患者治療效果並擴大市場。因此，對先進治療的需求正在推動市場成長。

醫療服務有限

醫療保健機會有限限制了患者及時接受診斷、護理和治療的能力，嚴重阻礙了糖尿病潰瘍治療市場的成長。這個問題在農村和低收入地區尤其普遍，因為這些地區獲得專科醫療中心和合格醫療專業人員的機會有限。因此，延遲或不充分的治療會增加併發症的風險，導致截肢率上升和對先進治療的需求減少，最終減緩市場成長潛力。

COVID-19 的影響

COVID-19 疫情對糖尿病潰瘍治療市場產生了重大影響，導致醫療服務中斷、患者就診量減少以及選擇性手術延遲。醫院新冠肺炎病例不堪重負，人們的注意力不再集中在糖尿病潰瘍等非緊急情況。結果，市場成長放緩。然而，疫情加速了遠端醫療和居家照護解決方案的採用，為糖尿病潰瘍的遠端系統管理和治療提供了新的機會。

預計口腔炎細分市場在預測期內將佔最大佔有率

糖尿病患者發生口腔潰瘍的風險通常是由於血糖控制不佳造成的，因此預計口腔潰瘍領域將在預測期內佔據最大的市場佔有率。這些潰瘍需要專門的治療，因為它們可能導致感染疾病等併發症並影響您的整體健康。人們對糖尿病治療中足部和口腔潰瘍管理的認知不斷提高，以及創傷治療和感染管理的進步，推動了對綜合治療方案的需求，從而推動了市場成長。

預計預測期內居家醫療領域將實現最高的複合年成長率。

預計預測期內居家醫療領域將呈現最高的成長率。這是因為對於專業和客製化治療的需求不斷增加，居家醫療提供者現在提供創傷護理、感染控制和足部護理建議，以便更快地康復。此外，遠端醫療和遠端監控的改進使醫療專業人員能夠監控患者的進展並最佳化治療方法。由於居家照護的轉變減少了住院時間和費用，糖尿病潰瘍治療市場正在擴大。

比最大的地區

在預測期內，由於糖尿病盛行率上升、人口老化以及人們對糖尿病足部護理認知的提高，預計北美將佔據最大的市場佔有率。先進敷料和生技藥品等傷口護理技術的進步以及醫療保健基礎設施的改善促進了市場的成長。此外，政府措施、增加醫療支出和預防保健的轉變也是主要促進因素。對創新治療和改善患者結果的需求進一步推動了市場擴張。

複合年成長率最高的地區

預計預測期內亞太地區將呈現最高的複合年成長率。這是由於糖尿病盛行率不斷上升、人們對糖尿病足部併發症認知的提高以及傷口護理技術的進步。人口老化和醫療保健機會的改善推動了對有效治療的需求。此外，生技藥品、先進敷料和創傷護理產品的創新也促進了市場的成長。政府舉措以及醫療保健基礎設施的改善也支持了該地區糖尿病潰瘍治療方案的擴大。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 主要企業的 SWOT 分析（最多 3 家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 介紹
  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第 4 章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球糖尿病潰瘍治療市場按類型

  • 介紹
  • 足部潰瘍
    • 神經缺血性潰瘍
    • 神經性潰瘍
    • 缺血性潰瘍
  • 腿部潰瘍
  • 口腔炎
  • 皮膚潰瘍
  • 其他

6. 全球糖尿病潰瘍治療市場依治療類型分類

  • 介紹
  • 創傷護理敷料
    • 抗菌敷料
    • 海藻酸鹽敷料
    • 水凝膠敷料
    • 泡棉敷料
    • 膜敷料
    • 親水膠體敷料
    • 其他創傷護理敷料
  • 生技藥品
    • 皮膚移植和皮膚替代
    • 生長因子
  • 創傷護理設備
    • 負壓傷口治療法
    • 高壓氧氣療法
    • 壓力釋放裝置
    • 電磁療法
    • 超音波治療

7. 全球糖尿病潰瘍治療市場（依最終用戶分類）

  • 介紹
  • 醫院
  • 門診手術中心
  • 居家醫療
  • 其他

8. 全球糖尿病潰瘍治療市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第9章 主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司概況

  • 3M Health Care
  • Acelity LP, Inc.
  • AOTI
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Cardinal Health
  • Coloplast Corp.
  • ConvaTec Group Plc
  • Emblation
  • Integra LifeSciences
  • IPCA Laboratories
  • Medline Industries, LP
  • Medtronic Plc
  • MIMEDX
  • Molnlycke Health Care AB
  • Novalead Pharma
  • Organogenesis Inc.
  • Smith & Nephew Plc
  • Tissue Regenix
Product Code: SMRC28553

According to Stratistics MRC, the Global Diabetic Ulcer Treatment Market is accounted for $4.5 billion in 2024 and is expected to reach $8.3 billion by 2030 growing at a CAGR of 10.5% during the forecast period. Diabetic ulcer therapy refers to medical measures used to repair ulcers or sores that occur on the skin of diabetics, usually on the feet or lower limbs. High blood sugar, nerve damage, and poor circulation all hinder the body's capacity to heal wounds, which leads to these ulcers. Blood sugar control, wound care, infection prevention, and maintaining good foot cleanliness are all part of the treatment. Advanced treatments include debridement, pressure relief equipment, dressings, and, in extreme situations, surgery, may be necessary in some situations.

According to the JAMA Network, the lifetime risk of developing a diabetic foot ulcer (DFU) is between 19% and 34%.

Market Dynamics:

Driver:

Rising Prevalence of Diabetes

The rising prevalence of diabetes is significantly driving the diabetic ulcer treatment market. As diabetes-related complications, including poor circulation and nerve damage, increase, the incidence of diabetic foot ulcers grows, creating a higher demand for effective treatments. This surge in cases fuels the need for advanced wound care solutions, including dressings, debridement, and infection management. Additionally, innovations in therapies and increased awareness about the importance of early intervention further contribute to the expansion of this market.

Restraint:

High Treatment Costs

High treatment costs are a significant hindrance to the growth of the diabetic ulcer treatment market. Patients, particularly in low-income regions, struggle with the affordability of advanced therapies, which limits access to effective care. The financial burden often leads to delays in treatment, worsening patient outcomes. Additionally, healthcare systems face challenges in covering expenses for long-term care, affecting market demand for high-cost diabetic ulcer treatments. This financial barrier slows the adoption of innovative treatment options.

Opportunity:

Advancements in Treatment Options

Advancements in treatment options are significantly driving the diabetic ulcer treatment market. Innovations like advanced wound dressings, growth factor therapies, stem cell treatments, and regenerative medicine offer improved healing and reduce complications. Additionally, technologies like negative pressure wound therapy (NPWT) and bioengineered skin substitutes enhance recovery rates. These breakthroughs are increasing the efficacy of treatments, leading to better patient outcomes and expanding the market. As a result, demand for advanced treatments, propelling market growth.

Threat:

Limited Healthcare Access

Limited healthcare access significantly hinders the growth of the diabetic ulcer treatment market by restricting patients' ability to receive timely diagnosis, care, and treatment. This issue is particularly prevalent in rural or low-income regions, where access to specialized medical centers and qualified healthcare professionals is limited. As a result, delayed or inadequate treatment increases the risk of complications, leading to higher amputation rates and reduced demand for advanced therapies, ultimately slowing the market's potential growth.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the diabetic ulcer treatment market, leading to disruptions in healthcare services, reduced patient visits, and delays in elective procedures. Hospitals were overwhelmed with COVID cases, shifting focus away from non-urgent conditions like diabetic ulcers. This resulted in a decline in market growth. However, the pandemic also accelerated the adoption of telemedicine and home-based care solutions, offering new opportunities for remote diabetic ulcer management and treatment.

The mouth ulcer segment is expected to be the largest during the forecast period

The mouth ulcer segment is expected to account for the largest market share during the forecast period, due to increased risk of oral ulcers in diabetic patients, often caused by poor blood sugar control. These ulcers can lead to complications like infections and affect overall health, prompting the need for specialized treatments. The growing awareness of managing both foot and oral ulcers in diabetic care, along with advances in wound healing and infection control, boosts demand for comprehensive treatment options, thus driving market growth.

The homecare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the homecare segment is predicted to witness the highest growth rate because of the growing knowledge and need for tailored treatment, homecare providers now include wound care, infection management, and foot care advice, allowing for speedier recovery. Furthermore, improvements in telemedicine and remote monitoring enable medical practitioners to monitor patients' progress and optimize treatment regimens. The market for diabetic ulcer therapy is expanding as a result of the move towards homecare, which lowers hospital stays and expenses.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to rising prevalence of diabetes, an aging population, and increasing awareness about diabetic foot care. Advancements in wound care technologies, such as advanced dressings and biologics, along with improved healthcare infrastructure, contribute to market growth. Additionally, government initiatives, growing healthcare spending, and a shift toward preventive care are key drivers. The need for innovative treatments and better patient outcomes further fuels market expansion.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR because rising prevalence of diabetes, increasing awareness of diabetic foot complications, and advancements in wound care technology. The growing aging population, coupled with higher healthcare access, boosts demand for effective treatments. Moreover, innovations in biologics, advanced dressings, and wound care products further contribute to market growth. Government initiatives, along with improved healthcare infrastructure, also support the expansion of diabetic ulcer treatment solutions in the region.

Key players in the market

Some of the key players in Diabetic Ulcer Treatment market include 3M Health Care, Acelity L.P., Inc., AOTI, B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health, Coloplast Corp., ConvaTec Group Plc, Emblation, Integra LifeSciences, IPCA Laboratories, Medline Industries, LP, Medtronic Plc, MIMEDX, Molnlycke Health Care AB, Novalead Pharma, Organogenesis Inc, Smith & Nephew Plc and Tissue Regenix.

Key Developments:

In October 2024, Royal Philips and Medtronic Neurovascular announced a strategic advocacy partnership. Delivering timely stroke care is crucial to saving lives and reducing long-term disability.

In September 2024, Medtronic plc announced the commercial launch of several software, hardware, and imaging innovations. These enhancements are designed to advance AiBLE, the Medtronic smart ecosystem of innovative navigation, robotics, data and AI, imaging, software and implants that enable more predictable outcomes in spine and cranial procedures.

In January 2024, Medtronic plc announced a strategic collaboration with Cardiac Design Labs (CDL) to launch, scale up, and expand access to CDL's novel diagnostic technology, Padma Rhythms, an external loop recorder (ELR) patch designed for comprehensive, long-term heart monitoring and diagnosis.

Types Covered:

  • Foot Ulcers
  • Leg Ulcers
  • Mouth Ulcer
  • Skin Ulcer
  • Other Types

Treatment Types Covered:

  • Wound Care Dressings
  • Biologics
  • Wound Care Devices

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Diabetic Ulcer Treatment Market, By Type

  • 5.1 Introduction
  • 5.2 Foot Ulcers
    • 5.2.1 Neuro-ischemic Ulcer
    • 5.2.2 Neuropathic Ulcer
    • 5.2.3 Ischemic Ulcer
  • 5.3 Leg Ulcers
  • 5.4 Mouth Ulcer
  • 5.5 Skin Ulcer
  • 5.6 Other Types

6 Global Diabetic Ulcer Treatment Market, By Treatment Type

  • 6.1 Introduction
  • 6.2 Wound Care Dressings
    • 6.2.1 Antimicrobial Dressing
    • 6.2.2 Alginate Dressing
    • 6.2.3 Hydrogel Dressing
    • 6.2.4 Foam Dressing
    • 6.2.5 Film Dressing
    • 6.2.6 Hydrocolloid Dressing
    • 6.2.7 Others Wound Care Dressings
  • 6.3 Biologics
    • 6.3.1 Skin Grafts and Substitutes
    • 6.3.2 Growth Factors
  • 6.4 Wound Care Devices
    • 6.4.1 Negative Pressure Wound Therapy
    • 6.4.2 Hyperbaric Oxygen Therapy
    • 6.4.3 Pressure Relief Devices
    • 6.4.4 Electromagnetic Therapy
    • 6.4.5 Ultrasound Therapy

7 Global Diabetic Ulcer Treatment Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Homecare
  • 7.5 Other End Users

8 Global Diabetic Ulcer Treatment Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M Health Care
  • 10.2 Acelity L.P., Inc.
  • 10.3 AOTI
  • 10.4 B. Braun Melsungen AG
  • 10.5 BSN Medical GmbH
  • 10.6 Cardinal Health
  • 10.7 Coloplast Corp.
  • 10.8 ConvaTec Group Plc
  • 10.9 Emblation
  • 10.10 Integra LifeSciences
  • 10.11 IPCA Laboratories
  • 10.12 Medline Industries, LP
  • 10.13 Medtronic Plc
  • 10.14 MIMEDX
  • 10.15 Molnlycke Health Care AB
  • 10.16 Novalead Pharma
  • 10.17 Organogenesis Inc.
  • 10.18 Smith & Nephew Plc
  • 10.19 Tissue Regenix

List of Tables

  • Table 1 Global Diabetic Ulcer Treatment Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Diabetic Ulcer Treatment Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Diabetic Ulcer Treatment Market Outlook, By Foot Ulcers (2022-2030) ($MN)
  • Table 4 Global Diabetic Ulcer Treatment Market Outlook, By Neuro-ischemic Ulcer (2022-2030) ($MN)
  • Table 5 Global Diabetic Ulcer Treatment Market Outlook, By Neuropathic Ulcer (2022-2030) ($MN)
  • Table 6 Global Diabetic Ulcer Treatment Market Outlook, By Ischemic Ulcer (2022-2030) ($MN)
  • Table 7 Global Diabetic Ulcer Treatment Market Outlook, By Leg Ulcers (2022-2030) ($MN)
  • Table 8 Global Diabetic Ulcer Treatment Market Outlook, By Mouth Ulcer (2022-2030) ($MN)
  • Table 9 Global Diabetic Ulcer Treatment Market Outlook, By Skin Ulcer (2022-2030) ($MN)
  • Table 10 Global Diabetic Ulcer Treatment Market Outlook, By Other Types (2022-2030) ($MN)
  • Table 11 Global Diabetic Ulcer Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 12 Global Diabetic Ulcer Treatment Market Outlook, By Wound Care Dressings (2022-2030) ($MN)
  • Table 13 Global Diabetic Ulcer Treatment Market Outlook, By Antimicrobial Dressing (2022-2030) ($MN)
  • Table 14 Global Diabetic Ulcer Treatment Market Outlook, By Alginate Dressing (2022-2030) ($MN)
  • Table 15 Global Diabetic Ulcer Treatment Market Outlook, By Hydrogel Dressing (2022-2030) ($MN)
  • Table 16 Global Diabetic Ulcer Treatment Market Outlook, By Foam Dressing (2022-2030) ($MN)
  • Table 17 Global Diabetic Ulcer Treatment Market Outlook, By Film Dressing (2022-2030) ($MN)
  • Table 18 Global Diabetic Ulcer Treatment Market Outlook, By Hydrocolloid Dressing (2022-2030) ($MN)
  • Table 19 Global Diabetic Ulcer Treatment Market Outlook, By Others Wound Care Dressings (2022-2030) ($MN)
  • Table 20 Global Diabetic Ulcer Treatment Market Outlook, By Biologics (2022-2030) ($MN)
  • Table 21 Global Diabetic Ulcer Treatment Market Outlook, By Skin Grafts and Substitutes (2022-2030) ($MN)
  • Table 22 Global Diabetic Ulcer Treatment Market Outlook, By Growth Factors (2022-2030) ($MN)
  • Table 23 Global Diabetic Ulcer Treatment Market Outlook, By Wound Care Devices (2022-2030) ($MN)
  • Table 24 Global Diabetic Ulcer Treatment Market Outlook, By Negative Pressure Wound Therapy (2022-2030) ($MN)
  • Table 25 Global Diabetic Ulcer Treatment Market Outlook, By Hyperbaric Oxygen Therapy (2022-2030) ($MN)
  • Table 26 Global Diabetic Ulcer Treatment Market Outlook, By Pressure Relief Devices (2022-2030) ($MN)
  • Table 27 Global Diabetic Ulcer Treatment Market Outlook, By Electromagnetic Therapy (2022-2030) ($MN)
  • Table 28 Global Diabetic Ulcer Treatment Market Outlook, By Ultrasound Therapy (2022-2030) ($MN)
  • Table 29 Global Diabetic Ulcer Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 30 Global Diabetic Ulcer Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 31 Global Diabetic Ulcer Treatment Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 32 Global Diabetic Ulcer Treatment Market Outlook, By Homecare (2022-2030) ($MN)
  • Table 33 Global Diabetic Ulcer Treatment Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.